Filtros de búsqueda

Lista de obras de A Michael Lincoff

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction ⬇️

artículo científico publicado el 28 de marzo de 2011

2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): a report of the American College of Cardiology Foundation/American Heart Associ

artículo científico publicado en 2011

2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Associati

artículo científico publicado en 2011

2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Associa

artículo científico publicado en 2011

2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat

artículo científico publicado en 2013

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol

artículo científico publicado en 2012

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol

artículo científico publicado en 2012

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

artículo científico publicado en 2018

2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials.

artículo científico publicado en 2018

A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study

artículo científico publicado en 2006

A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes

artículo científico publicado en 2006

A rare complication of infective endocarditis

scientific article published on 01 May 2010

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

artículo científico publicado en 2007

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Rev

artículo científico publicado en 2007

ADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study.

artículo científico publicado en 2018

Abciximab (ReoPro) removal during cardiopulmonary bypass with a hemoconcentrator

artículo científico publicado en 2000

Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarction.

artículo científico publicado en 2003

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials ∗ ∗A complete list of the principal investigators and study coordinators of the EPILOG (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP

artículo científico publicado en 2000

Abciximab readministration: results of the ReoPro Readministration Registry

artículo científico publicado en 2001

Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

artículo científico publicado en 2000

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

scientific article published on 01 July 2001

Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators

scientific article published on 01 March 1998

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile

artículo científico publicado el 1 de abril de 1992

Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial

artículo científico publicado en 2018

Acute pharmacological conversion of atrial fibrillation to sinus rhythm: is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration

scientific article published on 01 June 2008

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

artículo científico publicado en 2018

Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model

scientific journal article

An overview of the results of the EPIC trial

artículo científico publicado en 1995

Analysis and comparison of operator-specific outcomes in interventional cardiology. From a multicenter database of 4860 quality-controlled procedures

artículo científico publicado en 1996

Angiographic Adverse Events, Creatine Kinase-MB Elevation, and Ischemic End Points Complicating Percutaneous Coronary Intervention (a REPLACE-2 Substudy)

Anthracycline-induced cardiotoxicity

scientific article published on 01 July 1996

Anti-inflammatory stent coatings: dexamethasone and related compounds

scientific article published on 01 September 1998

Anticoagulant and antiplatelet drugs

artículo científico publicado en 2001

Anticoagulation with bivalirudin for off-pump coronary artery bypass grafting: the results of the EVOLUTION-OFF study

artículo científico publicado en 2006

Antiplatelet agents in ischemic heart disease

artículo científico publicado en 2012

Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study

scientific article published on 01 June 2002

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial

artículo científico

Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

artículo científico publicado en 2008

Antithrombotic therapy in patients undergoing percutaneous coronary intervention

artículo científico publicado en 2001

Antithrombotic therapy with intracoronary stenting.

artículo científico publicado en 1997

Aspirin for primary prevention of atherosclerotic cardiovascular events

artículo científico publicado en 2020

Assessment of hemostatic activation during cardiopulmonary bypass for coronary artery bypass grafting with bivalirudin: results of a pilot study

artículo científico publicado en 2005

Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial

artículo científico publicado en 2018

Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: Rationale and design of the ACCELERATE trial.

artículo científico publicado en 2015

Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial

scientific article published on 01 April 2019

Association of Lowering Low-Density Lipoprotein Cholesterol With Contemporary Lipid-Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta-Analysis

Association of adoption of transradial access for percutaneous coronary intervention in ST elevation myocardial infarction with door-to-balloon time

scientific article published on 27 February 2020

Association of glycemic control with mortality in patients with diabetes mellitus undergoing percutaneous coronary intervention

artículo científico publicado en 2014

Association of prerandomization anticoagulant switching with bleeding in the setting of percutaneous coronary intervention (A REPLACE-2 analysis)

artículo científico publicado en 2007

Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long-Term Mortality After Noncardiac Vascular Surgery

artículo científico publicado en 2017

Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary intervention

scientific article published on 01 November 1999

Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppressio

artículo científico publicado en 2001

Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trial

artículo científico publicado en 2019

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

artículo científico publicado en 2003

Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial

artículo científico publicado en 2007

Bivalirudin for patients with acute coronary syndromes

artículo científico publicado en 2006

Bivalirudin in PCI: an overview of the REPLACE-2 trial

artículo científico publicado en 2004

Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial

scientific article published on 01 March 2007

Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials ⬇️

artículo científico publicado el 15 de octubre de 2003

Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial).

artículo científico publicado en 2005

Bivalirudin vs heparin in percutaneous coronary intervention: a pooled analysis

artículo científico publicado en 2005

Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET).

artículo científico publicado en 2002

Bleeding complications of unfractionated heparin

artículo científico publicado en 2010

Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

artículo científico publicado en 2011

Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model

artículo científico publicado en 2003

Canakinumab to reduce deterioration of cardiac and respiratory function in SARS-CoV-2 associated myocardial injury with heightened inflammation (canakinumab in Covid-19 cardiac injury: The three C study)

scientific article published on 24 August 2020

Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction

artículo científico publicado en 2014

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

artículo científico publicado en 2016

Cardiovascular safety evaluation in the development of new drugs for diabetes mellitus

artículo científico publicado en 2014

Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting

artículo científico publicado en 2013

Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model

artículo científico publicado en 2005

Cell adhesion molecules in coronary artery disease

scientific article published on 01 December 1994

Characterisation of the unsteady transport of labelled species in permeable capillaries: role of convective dispersion

artículo científico publicado el 1 de noviembre de 1983

Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).

artículo científico publicado en 1995

Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes

artículo científico publicado en 2005

Chest pain--a strong predictor of adverse cardiac events following precutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISENT])]

scientific article published on 01 December 1999

Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT)

artículo científico publicado en 2000

Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials.

artículo científico publicado en 2017

Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender

article

Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade

artículo científico publicado en 2000

Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk

artículo científico publicado en 2005

Clinical experience with abciximab during coronary revascularisation: an overview

artículo científico publicado en 1998

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

artículo científico publicado en 1999

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II

artículo científico publicado en 1999

Clinical outcomes of drug-eluting versus bare-metal in-stent restenosis

artículo científico publicado en 2010

Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease

artículo científico publicado en 1998

Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).

artículo científico publicado en 2001

Clinical risk factors for ischemic complications after percutaneous coronary interventions: results from the EPIC trial. The EPIC Investigators

artículo científico publicado en 1999

Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience

artículo científico publicado en 1999

Combination therapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa receptor inhibitors: SPEEDing into GUSTO V.

artículo científico publicado en 2001

Comparing physician-specific two-year patient outcomes after coronary angiography: methodologic issues and results

artículo científico publicado en 1999

Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).

artículo científico publicado en 2005

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

artículo científico publicado en 2004

Comparison of clinical trial outcome patterns in patients following acute coronary syndromes and in patients with chronic stable atherosclerosis.

artículo científico publicado en 2014

Comparison of outcomes of unprotected left main versus multivessel coronary artery interventions

artículo científico publicado en 2011

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial

artículo científico publicado en 2008

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

article

Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY Library

artículo científico publicado en 2004

Coronary Artery Bypass Surgery Compared With Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Treatment in Patients With Acute Coronary Syndrome: Analysis From the ACUITY Trial

artículo científico publicado en 2015

Correlation of Point-of-Care ecarin clotting time versus activated clotting time with bivalirudin concentrations ⬇️

artículo científico publicado el 1 de mayo de 2003

Cost-effectiveness of platelet glycoprotein IIb/IIIa inhibition with eptifibatide in patients with non-ST-elevation acute coronary syndromes

artículo científico publicado en 2000

Coupling drug and catheter therapy for myocardial infarction

artículo científico publicado en 2004

Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes

artículo científico publicado en 2004

Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward

artículo científico publicado en 2012

Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials

artículo científico publicado en 2001

Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.

artículo científico publicado en 2007

Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators

artículo científico publicado en 1998

Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa blockade: the triad revisited

artículo científico publicado en 2004

Differences in Safety of Non-Steroidal Anti-Inflammatory Drugs in Patients with Osteoarthritis and Rheumatoid Arthritis: A Randomized Clinical Trial

artículo científico publicado en 2017

Differences in cardioprotective efficacy of adrenergic receptor antagonists and Ca2+ channel antagonists in an animal model of dilated cardiomyopathy. Effects on gross morphology, global cardiac function, and twitch force

scientific article published on 01 December 1993

Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measure

artículo científico publicado en 2017

Direct thrombin inhibition appears to be a safe and effective anticoagulant for percutaneous bypass graft interventions

Direct thrombin inhibitors

scientific article published on 01 July 2005

Direct thrombin inhibitors for non-ST–segment elevation acute coronary syndromes: what, when, and where? ⬇️

artículo científico publicado el 1 de octubre de 2003

Does eptifibatide confer a greater benefit to patients with unstable angina than with non-ST segment elevation myocardial infarction? Insights from the PURSUIT Trial

artículo científico publicado en 2002

Does stenting prevent diabetic arterial shrinkage after percutaneous coronary revascularization? ⬇️

artículo científico publicado el 2 de septiembre de 1997

Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions

Drug-eluting stent fracture and acute coronary syndrome

scientific article published on July 2009

Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis

artículo científico publicado en 2010

Dual antiplatelet therapy for acute coronary syndromes: How long to continue?

artículo científico publicado en 2016

Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor

artículo científico publicado en 1995

Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators

artículo científico publicado en 2000

Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial

artículo científico publicado en 2009

Economic assessment of platelet glycoprotein IIb/IIIa receptor blockade with abciximab and low-dose heparin during percutaneous coronary revascularization: results from the EPILOG randomized trial. Evaluation in PTCA to Improve Long-term Outcome wit

artículo científico publicado en 2000

Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes

artículo científico publicado en 2008

Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial

artículo científico publicado en 2004

Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen

artículo científico publicado en 2018

Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial

artículo científico publicado en 2020

Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial

scientific article published on 01 March 2020

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial

artículo científico publicado en 2020

Effect of Left Ventricular Conduction Delay on All-Cause and Cardiovascular Mortality (from the PRECISION Trial)

artículo científico publicado en 2019

Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT).

artículo científico publicado en 2002

Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial

artículo científico publicado en 2014

Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).

artículo científico publicado en 2014

Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention

scientific article published on 13 April 2007

Effect of anti-tumor necrosis factor-α polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic model

article

Effect of institutional volume and academic status on outcomes of coronary interventions: the IMPACT-II experience

artículo científico publicado en 1999

Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study

artículo científico publicado en 2001

Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes

artículo científico publicado en 2003

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial

artículo científico

Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: Pooled analysis from EPIC, EPILOG, and EPISTENT

Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial

artículo científico publicado en 2015

Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study

artículo científico publicado en 2009

Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center

artículo científico publicado en 2005

Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting

artículo científico publicado en 2004

Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis

artículo científico publicado en 2018

Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial

artículo científico publicado en 1996

Effects of the dual peroxisome proliferator-activated receptor-α/γ agonist aleglitazar on renal function in patients with stage 3 chronic kidney disease and type 2 diabetes: a Phase IIb, randomized study

artículo científico publicado en 2014

Efficacy and safety of bivalirudin in coronary artery disease patients with mild to moderate chronic kidney disease: Meta-analysis

artículo científico publicado en 2017

Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators

artículo científico publicado en 2011

Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention

artículo científico publicado en 2003

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

artículo científico publicado en 2017

Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial.

artículo científico publicado en 2013

Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease

article

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study

article

Evidence that angiotensin-converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting

article

Experimental determination and mathematical model of the transient incorporation of cholesterol in the arterial wall

artículo científico publicado en 1990

Exposure and response analysis of aleglitazar on cardiovascular risk markers and safety outcomes: An analysis of the AleCardio trial

artículo científico publicado en 2019

Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction

article

Fasiglifam-Induced Liver Injury in Patients With Type 2 Diabetes: Results of a Randomized Controlled Cardiovascular Outcomes Safety Trial

scientific article published on 01 December 2018

Final results of the ReoPro readministration registry

artículo científico publicado en 2004

First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation

artículo científico publicado en 2002

First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial

artículo científico publicado en 2005

GUSTO IV: expanding therapeutic options in acute coronary syndromes

artículo científico publicado en 2000

GUSTO V: combination drug treatment of acute myocardial infarction. Global Use of Strategies to Open Occluded Coronary Arteries.

artículo científico publicado en 2002

Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial

artículo científico publicado en 2009

Genome-Wide Polygenic Score and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study

scientific article published on 03 January 2020

Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUIT.

artículo científico publicado en 2000

Glycoprotein IIb-IIIa inhibition with abciximab and postprocedural risk assessment: Lessons from the evaluation of platelet IIb/IIIa inhibitor for stenting trial and implication for ad hoc use of glycoprotein IIb-IIIa antagonists

artículo científico publicado en 2002

Glycoprotein IIb/IIIa inhibitors

artículo científico publicado en 2004

Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

artículo científico publicado en 2000

Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findings

artículo científico publicado en 1998

Heparin and Control of Bleeding Complications During Platelet Glycoprotein IIb/IIIa Receptor Antagonist Therapy During Percutaneous Coronary Revascularization

scientific article published on 01 January 1996

Heparin monotherapy for percutaneous coronary intervention?

artículo científico publicado en 2014

Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome ⬇️

artículo científico publicado el 1 de febrero de 2011

Here and now--state of the art: optimal antithrombotic strategy for percutaneous coronary intervention-panel discussion

artículo científico publicado en 2004

Homeostasis Model Assessment of Insulin Resistance and Survival in Patients with Diabetes and Acute Coronary Syndrome.

artículo científico publicado en 2018

How do unfractionated and low-molecular-weight heparin compare after ST-segment elevation MI?

artículo científico publicado en 2006

Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction?

artículo científico publicado en 1993

Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention

artículo científico publicado en 1995

Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy

artículo científico publicado en 2019

Impact of Bleeding and Bivalirudin Therapy on Mortality Risk in Women Undergoing Percutaneous Coronary Intervention (from the REPLACE-2, ACUITY, and HORIZONS-AMI Trials).

artículo científico publicado en 2015

Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trial

artículo científico publicado en 2015

Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials.

artículo científico publicado en 2014

Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urge

scientific article published on 01 June 2011

Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)

artículo científico publicado en 2002

Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial

artículo científico publicado en 2011

Impact of cigarette smoking on extent of coronary artery disease and prognosis of patients with non-ST-segment elevation acute coronary syndromes: an analysis from the ACUITY Trial (Acute Catheterization and Urgent Intervention Triage Strategy).

artículo científico publicado en 2014

Impact of drug-eluting versus bare-metal stents on mortality in patients with anemia

artículo científico publicado en 2009

Impact of female sex on death and bleeding after fibrinolytic treatment of myocardial infarction in GUSTO V.

artículo científico publicado en 2007

Impact of female sex on outcome after percutaneous coronary intervention

article

Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.

artículo científico publicado en 2007

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials

artículo científico publicado en 2003

Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic Shock

artículo científico publicado en 2020

Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade

artículo científico publicado en 2003

In Reply: Aspirin for primary prevention

artículo científico publicado en 2020

In Reply: Assessing stable coronaryartery disease

scientific article published on 23 November 2020

In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis

artículo científico publicado en 2003

Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction

artículo científico publicado en 2014

Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention

Influence of Blockade at Specific Levels of the Coagulation Cascade on Restenosis in a Rabbit Atherosclerotic Femoral Artery Injury Model ⬇️

artículo científico publicado el 15 de noviembre de 1995

Influence of Diabetes on Long-Term Coronary Artery Bypass Graft Patency

artículo científico publicado en 2017

Influence of local delivery of the protein tyrosine kinase receptor inhibitor tyrphostin-47 on smooth-muscle cell proliferation in a rat carotid balloon-injury model

artículo científico publicado en 1997

Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization

artículo científico publicado en 2008

Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial

artículo científico publicado en 2014

Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot.

artículo científico publicado en 2004

Interplay between PCI access site, anticoagulant agent, and bleeding: Insights from the REGULATE-PCI randomized trial

artículo científico publicado en 2020

Interventional cardiology: does an optimal antithrombotic regimen for PCI exist?

artículo científico publicado en 2013

Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control study

artículo científico publicado en 1993

Intravenous platelet blockade with cangrelor during PCI.

artículo científico publicado en 2009

Is all unstable angina the same? Insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)

article

Is clopidogrel cardiovascular medicine's double-edged sword?

artículo científico publicado en 2006

Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

artículo científico publicado en 2012

Ischemic and bleeding outcomes in women treated with bivalirudin during percutaneous coronary intervention: a subgroup analysis of the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE)-2 trial

artículo científico publicado en 2006

Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein IIb/IIIa blockade compared to heparin with routine glycoprotein IIb/IIIa blockade: a REPLACE-2 substudy

artículo científico publicado en 2004

Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force

artículo científico publicado en 2007

Local adenoviral-mediated inducible nitric oxide synthase gene transfer inhibits neointimal formation in the porcine coronary stented model

Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model

artículo científico publicado en 2002

Local drug delivery for the prevention of restenosis. Fact, fancy, and future

artículo científico publicado en 1994

Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty

artículo científico

Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials

artículo científico

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

artículo científico publicado en 2004

Magnitude and consequences of missing the acute infarct-related circumflex artery

artículo científico publicado en 2009

Major adverse cardiovascular events with basal insulin peglispro versus comparator insulins in patients with type 1 or type 2 diabetes: a meta-analysis

artículo científico publicado en 2016

Management of acute coronary syndromes with emphasis on new information for the treatment of ST-segment elevation acute myocardial infarction

scientific article published on 01 February 2002

Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial

artículo científico publicado en 2000

Management of the patient with diabetes and coronary artery disease: a contemporary review

artículo científico publicado en 2013

Managing acute coronary syndromes: decades of progress

artículo científico publicado en 2014

Managing adverse effects and drug-drug interactions of antiplatelet agents

artículo científico publicado en 2011

Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries

artículo científico

Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites

artículo científico publicado en 2007

Minimal myocardial damage during coronary intervention is associated with impaired outcome

article published in 1999

Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?

artículo científico publicado en 2002

Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis

artículo científico publicado en 1998

Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial

artículo científico publicado en 2002

Mortality benefit of beta blockade in patients with acute coronary syndromes undergoing coronary intervention: pooled results from the Epic, Epilog, Epistent, Capture and Rapport Trials

artículo científico publicado en 2003

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

artículo científico publicado en 2002

Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus

artículo científico publicado en 2001

New Decade, New FDA Guidance for Diabetes Drug Development: Lessons Learned and Future Directions

artículo científico publicado en 2020

Off-pump coronary artery bypass with bivalirudin for patients with heparin-induced thrombocytopenia or antiplatelet factor four/heparin antibodies

artículo científico publicado en 2007

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy

scientific article published on 01 December 1999

Optimizing use of revascularization and clinical outcomes in ST-elevation myocardial infarction: insights from the GUSTO-V trial

article

Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial

artículo científico publicado en 2004

Outcome of acute myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab

artículo científico publicado en 2002

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

scientific article published in The Lancet

Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial

artículo científico publicado en 2009

Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials

artículo científico publicado en 2004

Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial

article

Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials

artículo científico publicado en 2009

Patients at high risk for ischemic complications

artículo científico publicado en 1994

Patients with acute coronary syndromes without persistent ST elevation undergoing percutaneous coronary intervention benefit most from early intervention with protection by a glycoprotein IIb/IIIa receptor blocker

artículo científico publicado en 2002

Percutaneous coronary intervention for acute coronary syndrome: no difference in 48-h bleeding rate or vascular access-site complications with low- or standard-dose unfractionated heparin in patients initially treated with fondaparinux ⬇️

artículo científico publicado el 12 de enero de 2011

Percutaneous coronary revascularization in coronary artery disease: lessons from a single center experience

artículo científico publicado en 2012

Percutaneous support devices for high risk or complicated coronary angioplasty

scientific article published on March 1991

Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model

scientific journal article

Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.

artículo científico publicado en 2001

Pharmacologic inhibition of platelet function: correlation between in vitro tests of platelet function and clinical outcomes

artículo científico publicado en 2008

Pharmacotherapy During Saphenous Vein Graft Intervention

artículo científico publicado en 2013

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

artículo científico publicado en 2007

Planned Versus Provisional Use of Glycoprotein IIb/IIIa Inhibitors in Smokers Undergoing Percutaneous Coronary Intervention

Plasma Aldosterone Levels Are Not Associated With Cardiovascular Events Among Patients With High-Risk Vascular Disease: Insights From the ACCELERATE Trial

scientific article published on 22 November 2019

Platelet glycoprotein IIb/IIIa inhibitors combined with fibrinolytic agents to treat acute myocardial infarction

artículo científico publicado en 2001

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

artículo científico publicado en 2000

Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Recepto

artículo científico publicado en 1998

Platelet inhibition with cangrelor in patients undergoing PCI.

artículo científico publicado en 2009

Platelet, Not Endothelial, P-Selectin Is Required for Neointimal Formation After Vascular Injury

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study

artículo científico publicado en 2001

Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome

artículo científico publicado en 2017

Potent complementary clinical benefit of abciximab and stenting during percutaneous coronary revascularization in patients with diabetes mellitus: results of the EPISTENT trial

artículo científico publicado en 2000

Poverty, process of care, and outcome in acute coronary syndromes

artículo científico publicado en 2003

Prasugrel for acute coronary syndromes: faster, more potent, but higher bleeding risk

artículo científico publicado en 2009

Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer

artículo científico publicado en 2016

Prediction of 1-year mortality and impact of bivalirudin therapy according to level of baseline risk: A patient-level pooled analysis from three randomized trials

artículo científico publicado en 2015

Predictive models for short- and long-term adverse outcomes following discharge in a contemporary population with acute coronary syndromes

artículo científico publicado en 2013

Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial

scientific article published on 01 February 2011

Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial

artículo científico publicado en 2007

Predictors of mortality in hospital survivors with type 2 diabetes mellitus and acute coronary syndromes

artículo científico publicado en 2017

Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators

artículo científico publicado en 2000

Prevalence of conventional risk factors in patients with coronary heart disease

artículo científico publicado en 2003

Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model

article

Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

artículo científico publicado en 2012

Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy

Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey

article

Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial

artículo científico publicado en 2005

Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention

artículo científico publicado en 2014

Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy

artículo científico publicado en 2001

Prognostic importance of new small Q waves following non-ST-elevation acute coronary syndromes

artículo científico publicado en 2003

Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification

artículo científico publicado en 2003

Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial

artículo científico

Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Interven

artículo científico publicado en 2009

Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions

artículo científico publicado en 2000

Prospective case-control comparison of percutaneous transluminal coronary revascularization in patients with multivessel disease treated in 1986-1987 versus 1991: improved in-hospital and 12-month results. Multivessel Angioplasty Prognosis Study (MA

scientific article published on 01 April 1995

Provisional glycoprotein IIb/IIIa blockade in a randomized investigation of bivalirudin versus heparin plus planned glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Predictors and outcome in the Randomized Evaluation in Per

Quantification of the effect of clopidogrel on enzymatic infarct size related to a percutaneous coronary intervention in patients with acute coronary syndromes: insights from the CHAMPION percutaneous coronary intervention trial

artículo científico publicado en 2013

Quantitative evaluation of local drug delivery using the InfusaSleeve catheter

artículo científico publicado en 1997

REGULATE-PCI trial--Author's reply

artículo científico publicado en 2016

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial

artículo científico publicado en 2018

Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

scientific article published on 01 July 1994

Rapid platelet-function assay: an automated and quantitative cartridge-based method

artículo científico publicado en 1999

Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acu

artículo científico publicado en 2016

Rationale and design of ApoA-I event reducing in ischemic syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute my

artículo científico publicado en 2020

Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis

artículo científico publicado en 2009

Real-world bare metal stenting: identification of patients at low or very low risk of 9-month coronary revascularization

artículo científico publicado en 2004

Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

artículo científico publicado en 2003

Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion

scientific article published on 01 July 2002

Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology

article

Reduction in the need for unplanned stenting with the use of platelet glycoprotein IIb/IIIa blockade in percutaneous coronary intervention

artículo científico publicado en 1998

Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials

article

Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction

artículo científico publicado en 2008

Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality

article by Vivek Rajagopal et al published July 2004 in American Journal of Cardiology

Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention

artículo científico publicado en 2004

Response to Letter Regarding Article, "Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease"

Restenosis--an open file

artículo científico publicado en 1996

Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial

artículo científico publicado en 2002

Risk factors for premature coronary artery disease and determinants of adverse outcomes after revascularization in patients < or =40 years old.

artículo científico publicado en 2003

Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction Dichotomous response as a function of age in the GUSTO V trial

article

Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention

artículo científico publicado en 2001

Role of longitudinal diffusion in the extravascular pulmonary space on parameter estimates derived from data of multiple indicator dilution

artículo científico publicado en 1982

Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial

artículo científico

Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition

artículo científico publicado en 2003

Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials

artículo científico publicado en 2016

Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).

artículo científico publicado en 2016

Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Interventio

artículo científico publicado en 2008

Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and

artículo científico publicado en 2008

Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency

artículo científico publicado en 2002

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study

artículo científico publicado en 2003

Safety profile and bleeding risk of ticagrelor compared with clopidogrel

artículo científico publicado en 2012

Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design

scientific article published on 17 July 2020

Sharing Data from Cardiovascular Clinical Trials--A Proposal

artículo científico publicado en 2016

Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? Yes.

artículo científico publicado en 2004

Should patients on long-term warfarin take aspirin for heart disease?

artículo científico publicado en 2008

Should patients with stable ischemic heart disease undergo revascularization?

artículo científico publicado en 2016

Significance of a coronary artery with Thrombolysis in Myocardial infarction grade 2 flow “patency” (outcome in the Thrombolysis and Angioplasty in Myocardial Infarction trials)

artículo científico publicado en 1995

Smoking, clopidogrel, and mortality in patients with established cardiovascular disease

artículo científico publicado en 2009

Stable coronary artery disease: Intervene or not?

artículo científico publicado en 2020

Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators

artículo científico publicado en 1997

Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group

artículo científico publicado en 2009

Stent scrutiny

artículo científico publicado en 2000

Stent-assisted detachable coil embolization of pseudoaneurysms in the coronary circulation

artículo científico publicado en 2006

Strategies for the development of new PPAR agonists in diabetes

scientific article published on May 2010

Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators

artículo científico publicado en 1999

Successful coronary angioplasty in two patients with cardiogenic shock using the Nimbus Hemopump support device

artículo científico publicado en 1990

Successful treatment of aortic root dissection complicated with extensive myocardial infarction using the total artificial heart

artículo científico publicado en 2017

Sustained Local Delivery of Dexamethasone by a Novel Intravascular Eluting Stent to Prevent Restenosis in the Porcine Coronary Injury Model

article

Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade

artículo científico publicado en 1999

Targeting the use of platelet IIb/IIIa inhibitors: treatment of acute myocardial infarction.

artículo científico publicado en 2002

The GUSTO-V clinical trial

artículo científico publicado en 2002

The Influence of Peripheral Arterial Disease on Outcomes

article

The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial

artículo científico publicado en 2000

The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial

artículo científico publicado en 2017

The Role of Lipoprotein (a) as a Marker of Residual Risk in Patients With Diabetes and Established Cardiovascular Disease on Optimal Medical Therapy: Post Hoc Analysis of ACCELERATE

scientific article published on 05 December 2019

The association between early ventricular arrhythmias, renin-angiotensin-aldosterone system antagonism, and mortality in patients with ST-segment-elevation myocardial infarction: Insights from Global Use of Strategies to Open coronary arteries (GUST

artículo científico publicado en 2009

The benefit of abciximab in percutaneous coronary revascularization is not device-specific

article

The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctions

artículo científico publicado en 1998

The haemoglobin glycation index as predictor of diabetes-related complications in the AleCardio trial

artículo científico publicado en 2017

The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study

article

The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial

article

The role of clopidogrel in the management of ischemic heart disease

artículo científico publicado en 2007

The role of spironolactone in the treatment of patients with refractory hypertension

artículo científico publicado en 2002

The safety of a bivalirudin-based approach in patients undergoing rotational atherectomy

artículo científico publicado en 2007

The use and limitations of unfractionated heparin

artículo científico publicado en 2010

The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends

artículo científico publicado en 2000

Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus

artículo científico publicado en 2010

Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators

artículo científico publicado en 2001

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

artículo científico publicado en 2011

Thrombolytic Therapy: The Treatment of Choice in Acute Myocardial Infarction

artículo científico publicado en 1997

Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group

scientific article published on 01 December 1993

Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial

artículo científico publicado en 2001

Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II)

article

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

artículo científico publicado en 2008

Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization

artículo científico publicado en 1998

Trickle down thrombolysis

artículo científico publicado en 1993

Update on Pharmacology for Restenosis

scientific article published on 01 May 2001

Use of bivalirudin during percutaneous coronary intervention in patients with diabetes mellitus: an analysis from the randomized evaluation in percutaneous coronary intervention linking angiomax to reduced clinical events (REPLACE)-2 trial

artículo científico publicado en 2005

Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes

artículo científico publicado en 2006

Use of ticlopidine and cilostazol after intracoronary drug-eluting stent placement in a patient with previous clopidogrel-induced thrombotic thrombocytopenic purpura: a case report

artículo científico publicado en 2006

Utility of CMR Markers of Myocardial Injury in Predicting LV Functional Recovery: Results from PROTECTION AMI CMR Sub-study.

artículo científico publicado en 2015

Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade

artículo científico publicado en 2005

Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial

artículo científico

What Role for Glycoprotein IIb/IIIa Inhibition in Contemporary Coronary Intervention?

artículo científico publicado en 2015

abciximab survival advantage following percutaneous coronary intervention is predicted by clinical risk profile

article

beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise

artículo científico publicado en 2001

β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda